Brown Vialetto Van Laere syndrome: first Peruvian case report

Síndrome de Brown Vialetto Van Laere, reporte de primer caso peruano

##plugins.themes.bootstrap3.article.main##

Peggy Carol Martínez-Esteban
Kelvin Harold Alvarez-Toledo
Edson Jair Mattos-Castillo
Carlos Méndez-Dávalos
Abstract

The Brown Vialetto Van Laere Syndrome (BVVLS), also known as Riboflavin Transporter Deficiency, is an autosomal recessive neurodegenerative disorder that is infrequently observed. This condition is associated with mutations in the SLC52A2 and SLC52A3 genes, which code for the riboflavin transporter.
Clinically, it is characterized by progressive ponto-bulbar palsy and sensorineural hearing loss. We describe the clinical presentation of a 1 year and 10 months old boy diagnosed with BVVLS. This patient experienced progressive ponto-bulbar palsy, respiratory compromise, and sensorineural hearing loss
but showed a positive response to the treatment implemented. Through genetic studies, a homozygous mutation in the SLC52A3 gene, specifically the c.1156T>C (p.Cys386Arg) variant, was identified. Upon conducting the segregation study in the parents, the same variant was detected in a heterozygous state.
The Brown Vialetto Van Laere Syndrome is a potentially treatable condition, highlighting the importance of its accurate diagnosis and the early empirical supplementation with riboflavin.

Keywords

Downloads

Download data is not yet available.

##plugins.themes.bootstrap3.article.details##

References

Jaeger B, Bosch AM. Clinical presentation and outcome of riboflavin transporter deficiency: mini review after five years of experience. J Inherit Metab Dis. 2016;39(4):559-64. doi: 10.1007/s10545-016-9924-2

O'Callaghan B, Bosch AM, Houlden H. An update on the genetics, clinical presentation, and pathomechanisms of human riboflavin transporter deficiency. J Inherit Metab Dis. 2019;42(4):598-607. doi: 10.1002/jimd.12053

Thulasi V, Veerapandiyan A, Pletcher BA, Tong CM, Ming X. A Case of Brown-Vialetto-Van Laere Syndrome Due To a Novel Mutation in SLC52A3 Gene: Clinical Course and Response to Riboflavin. Child Neurol Open. 2017;4:2329048X17725610. doi: 10.1177/2329048X17725610

Manole A, Jaunmuktane Z, Hargreaves I, Ludtmann MHR, Salpietro V, Bello OD, et al. Clinical, pathological and functional characterization of riboflavin-responsive neuropathy. Brain. 2017;140(11):2820-37. doi: 10.1093/brain/awx231

Allison T, Roncero I, Forsyth R, Coffman K, Pichon JL. Brown- Vialetto-Van Laere Syndrome as a Mimic of Neuroimmune Disorders: 3 Cases From the Clinic and Review of the Literature. J Child Neurol. 2017;32(6):528-32. doi:10.1177/0883073816689517

Woodcock IR, Menezes MP, Coleman L, Yaplito-Lee J, Peters H, White SM, et al. Genetic, Radiologic, and Clinical Variability in Brown- Vialetto-van Laere Syndrome. Semin Pediatr Neurol. 2018 Jul;26:2-9. doi:10.1016/j.spen.2017.03.001.

Udhayabanu T, Subramanian VS, Teafatiller T, Gowda VK, Raghavan VS, Varalakshmi P, et al. SLC52A2 [p.P141T] and SLC52A3 [p.N21S] causing Brown-Vialetto-Van Laere Syndrome in an Indian patient: First genetically proven case with mutations in two riboflavin transporters. Clin Chim Acta. 2016;462:210-4. doi: 10.1016/j.cca.2016.09.022

Pillai NR, Amin H, Gijavanekar C, Liu N, Issaq N, Broniowska KA, et al. Hematologic presentation and the role of untargeted metabolomics analysis in monitoring treatment for riboflavin transporter deficiency. Am J Med Genet A. 2020;182(11):2781-7. doi: 10.1002/ajmg.a.61851

Kranthi P, Garuda BR, Gopi S, Kumar TS. Brown-Vialetto-Van Laere syndrome: A rare case report of MND mimic. Neurol India. 2020;68(5):1217-9. doi: 10.4103/0028-3886.299175

Camargos S, Guerreiro R, Bras J, Mageste LS. Late-onset and acute presentation of Brown-Vialetto-Van Laere syndrome in a Brazilian family. Neurol Genet. 2018;4(1):e215. doi: 10.1212/NXG.0000000000000215

Bashford JA, Chowdhury FA, Shaw CE. Remarkable motor recovery after riboflavin therapy in adult-onset Brown-Vialetto-Van Laere syndrome. Pract Neurol. 2017;17(1):53-6. doi: 10.1136/practneurol-2016-001488

Perez EE, Orange JS, Bonilla F, Chinen J, Chinn IK, Dorsey M, et al. Update on the use of immunoglobulin in human disease: A review of evidence. J Allergy Clin Immunol. 2017;139(3S):S1-46. doi: 10.1016/j.jaci.2016.09.023

Nimmo GAM, Ejaz R, Cordeiro D, Kannu P, Mercimek-Andrews S. Riboflavin transporter deficiency mimicking mitochondrial myopathy caused by complex II deficiency. Am J Med Genet A. 2018;176(2):399-403. doi: 10.1002/ajmg.a.38530

OJS System - Metabiblioteca |